3-nitropropionic acid has been researched along with 6-cyano-7-nitroquinoxaline-2,3-dione in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Derr-Yellin, E; Nicklas, WJ; Zeevalk, GD | 1 |
| Ludolph, A; Ludolph, AC; Riepe, M; Seelig, M; Spencer, PS | 1 |
| Kasischke, K; Ludolph, AC; Riepe, MW | 1 |
3 other study(ies) available for 3-nitropropionic acid and 6-cyano-7-nitroquinoxaline-2,3-dione
| Article | Year |
|---|---|
NMDA receptor involvement in toxicity to dopamine neurons in vitro caused by the succinate dehydrogenase inhibitor 3-nitropropionic acid.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Adenosine Triphosphate; Animals; Antihypertensive Agents; Cells, Cultured; Dizocilpine Maleate; Dopamine; Mesencephalon; N-Methylaspartate; Neurons; Nitro Compounds; Propionates; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Succinate Dehydrogenase | 1995 |
Increase of ATP levels by glutamate antagonists is unrelated to neuroprotection.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Adenosine Triphosphate; Animals; Culture Techniques; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Mice; Nerve Degeneration; Neurotoxins; Nitro Compounds; Oxidative Phosphorylation; Plant Extracts; Propionates | 1994 |
NMDA-antagonists reverse increased hypoxic tolerance by preceding chemical hypoxia.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Antihypertensive Agents; Brain Ischemia; Energy Metabolism; Excitatory Amino Acid Antagonists; Hypoxia, Brain; In Vitro Techniques; Male; Nitro Compounds; Oxygen Consumption; Propionates; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 1996 |